Atorvastatin Related Compound C Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Calcium Salt Atorvastatin impurity. Atorvastatin EP Impurity C. Atorvastatin Related Compound C

Atorvastatin Related Compound C Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Atorvastatin Related Compound C Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Hubei Jusheng Technology Co.,Ltd.	18871490254	linda@hubeijusheng.com	CHINA	28172	58
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
Career Henan Chemica Co	+86-0371-86658258 +8613203830695	laboratory@coreychem.com	China	30238	58
CR Corporation Limited	+8613062833949	fred.wen@crcorporation.cn	China	8647	58
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12373	58
Hefei TNJ Chemical Industry Co.,Ltd.	+86-0551-65418684 +8618949823763	sales@tnjchem.com	China	25356	58
Hangzhou MolCore BioPharmatech Co.,Ltd.	+86-057181025280; +8617767106207	sales@molcore.com	China	49734	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11922	58
Suzhou ARTK Medchem Co., Ltd.	+86-512-68323658 +86-18168183658	sales1@artkmedchem.com	China	39004	58

693793-53-2()Verwandte Suche:

---

• Atorvastatin Related Compound C (20 mg) (Difluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)- 2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt)
• Atorvastatin Related CoMpound C
• Difluoro iMpurity, or (3R,5R)-7-[3-(phenylcarbaMoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt
• Difluoro Atorvastatin SodiuM Salt
• Atorvastatin EP IMpurity C
• Difluoro Atorvastatin CalciuM Salt
• (betaR,deltaR)-2,3-Bis(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
• Atorvastatin impurity C
• (βR,δR)-2,3-Bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemicalcium salt
• Atorvastatin Related Compound C (20 mg) (Difluoro impurity, or Calcium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2))
• (3R,5R)-7-[3-(phenylcarbaMoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt
• Atorvastatin Related Compound C,Difluoro impurity, or(3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt
• Atorvastatin Calcium Hydrate impurity 24
• Atorvastatin EP IMP C
• (3R,5R)-7-(2,3-bis(4-fluorophenyl)
• Atorvastatin calcium-2
• Atorvastatin impurity 5/Atorvastatin EP Impurity C Calcium Salt/Difluoro Atorvastatin Calcium Salt/(3R,5R)-7-(2,3-bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid Calcium Salt
• Atorvastatin EP Impurity C Calcium Salt
• Atorvastatin Impurity 15（Atorvastatin EP Impurity C Calcium Salt）
• Atorvastatin USP RC C
• USP Impurity C
• (3R,5R)-7-[3-(Phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt
• (betaR,deltaR)-2,3-Bis(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemicalcium salt
• Calcium(3R,5R)-7-(2,3-bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate
• Fluoro Atorvastatin Sodium
• Atorvastatin Difluoro Analog
• USP Atorvastatin Related Compound C
• Difluoroatorvastatin calcium was used to evaluate the effect of difluoroatorvastatin calcium (calcium salt)"
• Difluoroatorvastatin calcium was used to evaluate the effect of difluoroatorvastatin calcium Atorvastatin calcium 2020 Pharmacopoeia Impurity III)"
• 38/5000 Difluoroatorvastatin calcium was used to evaluate the effect of difluoroatorvastatin calcium Atorvastatin calcium 2020 Pharmacopoeia Impurity III)"
• Atorvastatin EP Impurity CQ: What is Atorvastatin EP Impurity C Q: What is the CAS Number of Atorvastatin EP Impurity C Q: What is the storage condition of Atorvastatin EP Impurity C Q: What are the applications of Atorvastatin EP Impurity C
• Atorvastatin Related Compound C (Difluoro impurity, or Calcium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5 (1044549)
• Atorvastatin Impurity 15 Calcium Salt (Atorvastatin EP Impurity C Calcium Salt)
• Atorvastatin USP Related Compound C
• (βR,δR)-2,3-Βis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Αcid Calcium Salt
• (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-4- (phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5- dihydroxyheptanoate
• (3R,5R)-7-(2,3-bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate
• ((3R,5R)-7-(2,3-bis(4-fluorophenyl)-5-isopropyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate) calcium(II)
• 693793-53-2
• 693793-20-6
• CaC33H34F2N2O52
• C33H34F2N2O52Ca
• 11913